Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

Conditions:   Gallbladder Cancer;   Initially Unresectable;   the First Line Treatment Intervention:   Drug: Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab Sponsor:   Lu Wang, MD, PhD Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials